Premium Information is available for this item - Upgrade for $1 a day
6505-01-051-6511
Usp Levothyroxine Sodium Tablets
6505010516511 010516511 3P1026 SYNTHROID
November 2023
9
Marketplace 6505-01-051-6511
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-051-6511 5+ Documents (More...)
6505-01-051-6511 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-051-6511
Usp Levothyroxine Sodium Tablets 010516511 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-051-6511
nl 6505-17-118-5724 Levothyroxine Sodium Tablets 6505171185724 Tablets 6505190005134 6505-01-051-6511
Tablets 6505190010310 https//www.nsnlookup.com 6505/us 6505-01-051-6511 Usp Levothyroxine Sodium Tablets
Upgrade your Account Upgrade 6505-01-031-4739Usp Levothyroxine Sodium Tablets6505010314739 010314739 SYNTHROID
Usp Levothyroxine Sodium Tablets 010516511 your Account Upgrade 6505-01-051-6511Usp Levothyroxine
6505-17-118-5725 RQST Updated Every 6505190005134 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-051-6511
Usp Levothyroxine Sodium Tablets 010516511 6505190010310 fsc-6505/nl 6505-17-118-5724 Levothyroxine
Usp Levothyroxine Sodium Tablets 010516511 908-1822 Levothyroxine Sodium Tablets 010516511 https
596-5245 6505-21-908-1822 6505-00-227-9826 6505-19-001-0310 6505-01-145-8137 6505-01-313-6243 6505-01-051-6511
Restrictions 6505-01-051-6511
6505-01-051-6511 is a Usp Levothyroxine Sodium Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-01-051-6511
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
- United States of America (ZZ)
Approved Sources 6505-01-051-6511
- Part Number
- Manufacturer
- Status
- 3P1026
- Manufacturer
- 04687 - Baxter Healthcare Corp (Active)
- Incomplete Reference
- Incomplete Reference
- SYNTHROID
- 04687 - Baxter Healthcare Corp (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-051-6511
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 0.025 Milligrams Levothyroxine Sodium Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 5000.000 Tablets
NATO Stock Numbers Related to 6505-01-051-6511
Freight Information 6505-01-051-6511
6505-01-051-6511 has freight characteristics.. 6505-01-051-6511 has a variance between NMFC and UFC when transported by rail and the description should be consulted.